C Marcelo Falappa
Overview
Explore the profile of C Marcelo Falappa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haidar A, Lovblom L, Cardinez N, Gouchie-Provencher N, Orszag A, Tsoukas M, et al.
Nat Med
. 2022 May;
28(6):1269-1276.
PMID: 35551290
There is a need to optimize closed-loop automated insulin delivery in type 1 diabetes. We assessed the glycemic efficacy and safety of empagliflozin 25 mg d as add-on therapy to...
2.
Haidar A, Yale J, Lovblom L, Cardinez N, Orszag A, Falappa C, et al.
Diabetes Obes Metab
. 2021 Feb;
23(6):1272-1281.
PMID: 33528904
Aim: To assess whether adding empagliflozin to closed-loop automated insulin delivery could reduce the need for carbohydrate counting in type 1 diabetes (T1D) without worsening glucose control. Materials And Methods:...
3.
Ostrovski I, Lovblom L, Scarr D, Weisman A, Cardinez N, Orszag A, et al.
Can J Diabetes
. 2019 Oct;
44(3):229-235.
PMID: 31630987
Objectives: To better understand the dawn phenomenon in type 1 diabetes, we sought to determine its prevalence, timing and magnitude in studies specifically designed to assess basal insulin requirements in...
4.
Haidar A, Rabasa-Lhoret R, Legault L, Lovblom L, Rakheja R, Messier V, et al.
J Clin Endocrinol Metab
. 2015 Nov;
101(1):214-23.
PMID: 26523526
Context: The added benefit of glucagon in artificial pancreas systems for overnight glucose control in type 1 diabetes has not been fully explored. Objective: The objective of the study was...
5.
Orszag A, Falappa C, Lovblom L, Partridge H, Tschirhart H, Boulet G, et al.
Can J Diabetes
. 2015 Apr;
39(5):364-72.
PMID: 25827055
Objective: Clinical protocols for basal rate testing and adjustment are needed for effective insulin pump therapy. We evaluated the effects of a continuous glucose monitoring (CGM)-based semiautomated basal algorithm on...